glp-1 7-36 CAS 107444-51-9 Glucagon-like peptide 1 (GLP1, 7-36)
Description
Another 2024 study found that people with breast cancer and type 2 diabetes taking GLP-1 drugs had fewer major cardiovascular problems (conditions related to heart and blood vessels) after receiving cardiotoxic breast cancer treatments such as anthracyclines and HER2 inhibitors, compared to people not taking GLP-1 drugs

Long-term side risks could consist of the body generating antibodies against the drug, which could reduce its efficacy or cause new side effects

She says all of her patients who are on the Wegovy pill versus injectable drugs are on them because they're more affordable

[DOI] [PMC free article] [PubMed] [Google Scholar] 42.Beiroa D, Imbernon M, Gallego R, Senra A, Herranz D, Villarroya F, et al

About the Author : Carrie Forrest has a masters degree in public health with a specialty in nutrition and is a certified holistic nutritionist

doi: 10.1161/circulationaha.117.028136
